Natasha Antonovich, PharmD, BCPS

Article

Discontinuing Disease-Modifying Therapies in Nonactive Secondary Progressive MS:Review of the Evidence

Author:: Natasha Antonovich, PharmD, BCPS

Publish date: June 29, 2023

Background: There are currently no disease-modifying therapies (DMTs) on the market approved for nonactive sec...

Article

Multiple Sclerosis Medications in the VHA: Delivering Specialty, High-Cost, Pharmacy Care in a National System (FULL)

Author:: Natasha Antonovich, PharmD, BCPS

Publish date: April 1, 2021

Disease modifying therapies that offer advantages for patients with multiple sclerosis are entering clinical trials and are rapidly being approved....